Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists ; volume:8 ; number:4 ; day:19 ; month:7 ; year:2006 ; pages:1-15 ; date:8.2006
Arthritis Research & Therapy ; 8, Heft 4 (19.7.2006), 1-15, 8.2006
- Beteiligte Personen und Organisationen
-
Hamdi, Haïfa
Mariette, Xavier
Godot, Véronique
Weldingh, Karin
Hamid, Abdul Monem
Prejean, Maria-Victoria
Baron, Gabriel
Lemann, Marc
Puechal, Xavier
Breban, Maxime
Berenbaum, Francis
Delchier, Jean-Charles
Flipo, René-Marc
Dautzenberg, Bertrand
Salmon, Dominique
Humbert, Marc
Emilie, Dominique
SpringerLink (Online service)
- DOI
-
10.1186/ar1994
- URN
-
urn:nbn:de:1111-201605035441
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hamdi, Haïfa
- Mariette, Xavier
- Godot, Véronique
- Weldingh, Karin
- Hamid, Abdul Monem
- Prejean, Maria-Victoria
- Baron, Gabriel
- Lemann, Marc
- Puechal, Xavier
- Breban, Maxime
- Berenbaum, Francis
- Delchier, Jean-Charles
- Flipo, René-Marc
- Dautzenberg, Bertrand
- Salmon, Dominique
- Humbert, Marc
- Emilie, Dominique
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antituberculosis drugs
Production of tumour necrosis factor during murine cutaneous leishmaniasis
Clostridium Bacteria: Harnessing Tumour Necrosis for Targeted Gene Delivery
Antituberculosis chemotherapy : 50 tables
Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
Exogenous tumour necrosis factor α induces suppression of autoimmune arthritis
Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
Reduced lymphocyte count as an early marker for predicting infected pancreatic necrosis
Natural Inhibitors of Tumour Necrosis Factor-α Production, Secretion and Function
Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases
Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer
The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis
Antituberculosis drugs
Production of tumour necrosis factor during murine cutaneous leishmaniasis
Clostridium Bacteria: Harnessing Tumour Necrosis for Targeted Gene Delivery
Antituberculosis chemotherapy : 50 tables
Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
Exogenous tumour necrosis factor α induces suppression of autoimmune arthritis
Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
Reduced lymphocyte count as an early marker for predicting infected pancreatic necrosis
Natural Inhibitors of Tumour Necrosis Factor-α Production, Secretion and Function
Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases
Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer
The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis
Antituberculosis drugs
Production of tumour necrosis factor during murine cutaneous leishmaniasis
Clostridium Bacteria: Harnessing Tumour Necrosis for Targeted Gene Delivery
Antituberculosis chemotherapy : 50 tables
Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
Exogenous tumour necrosis factor α induces suppression of autoimmune arthritis
Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
Reduced lymphocyte count as an early marker for predicting infected pancreatic necrosis
Natural Inhibitors of Tumour Necrosis Factor-α Production, Secretion and Function
Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases
Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer